Skip to main content
Erschienen in: Journal of Gastrointestinal Cancer 4/2016

09.10.2015 | Case Report

Pancreatic Tumor Presenting as Diarrhea

verfasst von: Kalpit Devani, Dhara Chaudhari, Mark Young

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Excerpt

VIPoma, Verner-Morrison syndrome, is a rare functioning neuroendocrine tumor that secretes vasoactive intestinal polypeptide (VIP). It is also known as pancreatic cholera or WDHA syndrome (watery diarrhea, hypokalemia and hypo or achlorhydria). Verner and Morrison first described the symptoms of VIPoma in 1958 as watery diarrhea, hypokalemia and achlorhydria [1]. Approximately 90 % of cases arise from the pancreas but they may also occur in periganglionic tissue or other locations such as the adrenals, colon, bronchus, liver and sympathetic ganglia. VIPomas are found to be malignant in about 60–80 % cases and are metastatic at the time of diagnosis, with the liver being the most common site of metastasis [2]. Herein, we present a patient with chronic diarrhea who was found to have VIPoma and did well after surgical resection. …
Literatur
1.
Zurück zum Zitat Verner JV, Morrison AB. Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med. 1958;25(3):374–80.CrossRefPubMed Verner JV, Morrison AB. Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med. 1958;25(3):374–80.CrossRefPubMed
2.
Zurück zum Zitat Abu-Zaid A, Azzam A, Abudan Z, et al. Sporadic pancreatic vasoactive intestinal peptide-producing tumor (VIPoma) in a 47-year-old male. Hematol Oncol Stem Cell Ther. 2014;7:109–15.CrossRefPubMed Abu-Zaid A, Azzam A, Abudan Z, et al. Sporadic pancreatic vasoactive intestinal peptide-producing tumor (VIPoma) in a 47-year-old male. Hematol Oncol Stem Cell Ther. 2014;7:109–15.CrossRefPubMed
3.
Zurück zum Zitat Ghaferi AA, Chojnacki KA, Long WD, et al. Pancreatic VIPomas: subject review and one institutional experience. J Gastrointest Surg. 2008;12:382–93.CrossRefPubMed Ghaferi AA, Chojnacki KA, Long WD, et al. Pancreatic VIPomas: subject review and one institutional experience. J Gastrointest Surg. 2008;12:382–93.CrossRefPubMed
5.
Zurück zum Zitat Johnson JB, Marsden L, Samadder NJ. A rare cause of diarrhea: pancreatic VIPoma. Endoscopy. 2013;45(Suppl 2 UCTN):E311–2.PubMed Johnson JB, Marsden L, Samadder NJ. A rare cause of diarrhea: pancreatic VIPoma. Endoscopy. 2013;45(Suppl 2 UCTN):E311–2.PubMed
6.
Zurück zum Zitat King CM, Reznek RH, Dacie JE, Wass JA. Imaging islet cell tumours. Clin Radiol. 1994;49(5):295–303.CrossRefPubMed King CM, Reznek RH, Dacie JE, Wass JA. Imaging islet cell tumours. Clin Radiol. 1994;49(5):295–303.CrossRefPubMed
7.
Zurück zum Zitat Thoeni RF, Mueller-Lisse UG, Chan R, Do NK, Shyn PB. Detection of small functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity. Radiology. 2000;214(2):483–90.CrossRefPubMed Thoeni RF, Mueller-Lisse UG, Chan R, Do NK, Shyn PB. Detection of small functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity. Radiology. 2000;214(2):483–90.CrossRefPubMed
8.
Zurück zum Zitat Rindi G, Klöppel G, Alhman H, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449:395.CrossRefPubMedPubMedCentral Rindi G, Klöppel G, Alhman H, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449:395.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Strosberg JR, Cheema A, Weber JM, et al. Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications. Ann Surg. 2012;256:321.CrossRefPubMed Strosberg JR, Cheema A, Weber JM, et al. Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications. Ann Surg. 2012;256:321.CrossRefPubMed
10.
Zurück zum Zitat Strosberg JR, Cheema A, Weber J, et al. Prognostic validity of a novel American Joint Committee on Cancer Staging Classification for pancreatic neuroendocrine tumors. J Clin Oncol. 2011;29:3044.CrossRefPubMed Strosberg JR, Cheema A, Weber J, et al. Prognostic validity of a novel American Joint Committee on Cancer Staging Classification for pancreatic neuroendocrine tumors. J Clin Oncol. 2011;29:3044.CrossRefPubMed
11.
Zurück zum Zitat Roland CL, Bian A, Mansour JC, et al. Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypes. J Surg Oncol. 2012;105:595.CrossRefPubMed Roland CL, Bian A, Mansour JC, et al. Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypes. J Surg Oncol. 2012;105:595.CrossRefPubMed
12.
Zurück zum Zitat Bilimoria KY, Bentrem DJ, Merkow RP, et al. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. J Am Coll Surg. 2007;205:558.CrossRefPubMed Bilimoria KY, Bentrem DJ, Merkow RP, et al. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. J Am Coll Surg. 2007;205:558.CrossRefPubMed
Metadaten
Titel
Pancreatic Tumor Presenting as Diarrhea
verfasst von
Kalpit Devani
Dhara Chaudhari
Mark Young
Publikationsdatum
09.10.2015
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Cancer / Ausgabe 4/2016
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-015-9770-8

Weitere Artikel der Ausgabe 4/2016

Journal of Gastrointestinal Cancer 4/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.